RB
Rashminkumar Bipinchandra Shah
About Rashminkumar Bipinchandra Shah
Data last updated:
Rashminkumar Bipinchandra Shah is a Managing Director at Zydus Hospira Oncology Private Limited (since 2023) and Partner at Pleiades Ventures Llp (since 2023). The companies operate in Pharma and Real Estate and Construction. The 2 current companies with reported revenue have a combined latest revenue of ₹431 Cr; the largest is Zydus Hospira Oncology Private Limited at ₹431 Cr (FY 2025). Earlier, Rashminkumar Bipinchandra Shah was a Ceo(Kmp) at Alidac Pharmaceuticals Limited (2014–2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Zydus Hospira Oncology Private Limited U24230GJ2005PTC046246 | Managing Director | 16 Sep 2023 | 2005 | ₹431 Cr (FY 2025) | Active |
 Pleiades Ventures Llp ACA-4338 | Partner | 23 Aug 2023 | 2023 | ₹5,446 (FY 2026) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Alidac Pharmaceuticals Limited U24230GJ2005PLC046915 | Ceo(Kmp) | 17 Jun 2014 | 2005 | ₹57.16 Cr (FY 2019) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Rashminkumar Bipinchandra Shah
| Name | DIN | Company | Designation |
|---|---|---|---|
| Andrew David Chatfield | 07086776 | Zydus Hospira Oncology Private Limited | Director |
| Ganesh Narayan Nayak | 00017481 | Zydus Hospira Oncology Private Limited | Director |
| Kevin Sullivan | 10435917 | Zydus Hospira Oncology Private Limited | Director |
| Kit Yi Leung | 11277173 | Zydus Hospira Oncology Private Limited | Additional Director |
| Michael Brandon Braun | 11046580 | Zydus Hospira Oncology Private Limited | Director |
| Nareshkumar Natvarlal Prajapati | Zydus Hospira Oncology Private Limited | Company Secretary | |
| Prashant Sharma | 06812786 | Zydus Hospira Oncology Private Limited | Director |
| Sonya Kakkar | 09685184 | Zydus Hospira Oncology Private Limited | Director |
| Tushar Dhansukh Shroff | 08234045 | Zydus Hospira Oncology Private Limited | Additional Director |
| Vikramkumar Brijesh Shukla | 07241477 | Zydus Hospira Oncology Private Limited | Director |
| Aasit Vinaykant Shah | 10002044 | Pleiades Ventures Llp | Designated Partner |
| Mehul Parikh | 10002556 | Pleiades Ventures Llp | Designated Partner |
| Sheetal Aasit Shah | 10002045 | Pleiades Ventures Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rashminkumar Bipinchandra Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rashminkumar Bipinchandra Shah
Rashminkumar Bipinchandra Shah currently holds 2 directorships: Zydus Hospira Oncology Private Limited (Managing Director, since 16 Sep 2023, revenue ₹431 Cr (FY 2025)); Pleiades Ventures Llp (Partner, since 23 Aug 2023, revenue ₹5,446 (FY 2026)).
Rashminkumar Bipinchandra Shah was first appointed on 17 Jun 2014 as Ceo(Kmp) at Alidac Pharmaceuticals Limited. The most recent appointment on record is 16 Sep 2023 at Zydus Hospira Oncology Private Limited.
The 2 current companies of Rashminkumar Bipinchandra Shah that report revenue have a combined latest revenue of ₹431 Cr: Zydus Hospira Oncology Private Limited ₹431 Cr (FY 2025); Pleiades Ventures Llp ₹5,446 (FY 2026).
Rashminkumar Bipinchandra Shah held 1 earlier board appointment: Alidac Pharmaceuticals Limited (Ceo(Kmp), 17 Jun 2014 to 31 Jan 2019).
The current boards of Rashminkumar Bipinchandra Shah's companies include Andrew David Chatfield (Zydus Hospira Oncology Private Limited), Ganesh Narayan Nayak (Zydus Hospira Oncology Private Limited), Kevin Sullivan (Zydus Hospira Oncology Private Limited), Kit Yi Leung (Zydus Hospira Oncology Private Limited), Michael Brandon Braun (Zydus Hospira Oncology Private Limited), Nareshkumar Natvarlal Prajapati (Zydus Hospira Oncology Private Limited), among others.